Beam Therapeutics (BEAM) Profit After Tax (2019 - 2025)
Historic Profit After Tax for Beam Therapeutics (BEAM) over the last 7 years, with Q3 2025 value amounting to -$112.7 million.
- Beam Therapeutics' Profit After Tax fell 1661.36% to -$112.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$414.6 million, marking a year-over-year decrease of 18876.67%. This contributed to the annual value of -$376.7 million for FY2024, which is 18427.57% down from last year.
- As of Q3 2025, Beam Therapeutics' Profit After Tax stood at -$112.7 million, which was down 1661.36% from -$102.3 million recorded in Q2 2025.
- Over the past 5 years, Beam Therapeutics' Profit After Tax peaked at $142.8 million during Q4 2023, and registered a low of -$201.6 million during Q1 2021.
- Moreover, its 5-year median value for Profit After Tax was -$91.1 million (2024), whereas its average is -$78.6 million.
- Per our database at Business Quant, Beam Therapeutics' Profit After Tax crashed by 56176.37% in 2021 and then skyrocketed by 47236.17% in 2023.
- Beam Therapeutics' Profit After Tax (Quarter) stood at -$64.7 million in 2021, then skyrocketed by 40.73% to -$38.3 million in 2022, then skyrocketed by 472.36% to $142.8 million in 2023, then crashed by 163.27% to -$90.4 million in 2024, then fell by 24.76% to -$112.7 million in 2025.
- Its Profit After Tax stands at -$112.7 million for Q3 2025, versus -$102.3 million for Q2 2025 and -$109.3 million for Q1 2025.